recommandations d'un forum québécois sur la douleur neuropathique

1
Bibliographie
Algorithme de traitement de la douleur neuropathique
● Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). 1. Effects on dorsal
horn convergent neurones in the rat. Pain 1979; 6: 283-304.
● Merskey H, Bogduk N. Classification of chronic pain. 2nd eds IASP Task force on taxonomy. IASP
Press, Seattle, 1994.
● Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R,
Nurmikko T, Serra J. Neuropathic pain. Redefinition and a grading system for clinical and research
purposes. Neurology 2007 (http://www.neurology.org).
pour en savoir davantage
physiopAtholoGie
Marchand S. Physiopathologie de la douleur. Dans :
Pathologie médicale de l’appareil locomoteur. Bergeron
Y, Fortin L, Leclaire R (éd.), Montréal, Edisem
− Maloine, 2008, p. 979-1006.
préVAlence
Morley-Forster P. Prevalence of neuropathic pain and
the need for treatment. Pain Res Manage 2006;
11(Suppl. A): 5A-10A.
éVAluAtion
Bouhassira D et coll. Comparison of pain syndromes
associated with nervous or somatic lesions and
development of a new neuropathic pain diagnostic
questionnaire (DN4). Pain 2005; 114: 29-36.
Autres Guides de prAtiQue
● Dworkin RH, O’Connor AB, Backonja M, Farrar JT,
Finnerup NB, Jensen TS, Kalso EA, Loeser JD,
Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS,
Stacey BR, Treede RD,Turk DC, Wallace MS. Pharmacologic
management of neuropathic pain:
evidence-based recommendations. Pain 2007;
132(3): 237-51.
● Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP,
Sessle BJ, Coderre T, Morley-Forster PK, Stinson J,
Boulanger A, Peng P, Finley GA, Taenzer P, Squire
P, Dion D, Cholkan A, Gilani A, Gordon A, Henry J,
Jovey R, Lynch M, Mailis-Gagnon A, Panju A, Rollman
GB, Velly A; Canadian Pain Society. Pharmacological
management of chronic neuropathic
pain – consensus statement and guidelines from
the Canadian Pain Society. Pain Res Manag
2007; 12(1): 13-21.
● Attal N, Cruccu G, Haanpää M, Hansson P, Jensen
TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P;
EFNS Task Force. EFNS guidelines on pharmacological
treatment of neuropathic pain. Eur J Neurol
2006; 13(11): 1153-69.
● Gilron I, Watson CPN, Cahill CM, Moulin DE. Neuropathic
pain: a practical guide for the clinician.
CMAJ 2006; 175: 265-275.
coAnAlGésiQues
Antidépresseurs
Saarto T, Wiffen PJ. Antidepressants for neuropathic
pain. Cochrane Database Syst Rev 17 octobre
2007; (4): CD005454.
Anticonvulsivants
Wiffen P, Collins S, McQuay H, Carroll D, Jadad A,
Moore A. Anticonvulsant drugs for acute and chronic
pain. Cochrane Database Syst Rev 20 juillet
2005; (3): CD001133.
Cannabinoïdes
Beaulieu P, Ware M. Reassessment of the role of
cannabinoids in the management of pain. Curr
Opin Anaesthesiol 2007; 20: 473-7.
Kétamine
Hocking G, Cousins MJ. Ketamine in Chronic Pain
Management: An Evidence-Based Review. Anesth
Analg 2003; 97: 1730-9.
Lidocaïne
Khaliq W, Alam S, Puri N. Topical lidocaine for the
treatment of postherpetic neuralgia. Cochrane
Database Syst Rev 18 avril 2007; (2):
CD004846.
Méthadone
Sandoval JA, Furlan AD, Mailis-Gagnon A. Oral
Methadone for Chronic Non-Cancer Pain: A Systematic
Literature Review of Reasons for Administration,
Prescription Patterns, Effectiveness, and Side
Effects. Clin J Pain 2005; 21(6): 503-512.
Opioïdes
Eisenberg. Efficacy and Safety of Opioid Agonists in
the Treatment of Neuropathic Pain of Nonmalignant
Origin: Systematic Review and Meta-Analysis
of Randomized Controlled Trials. JAMA 2005;
293(24): 3043-52.
Techniques effractives
Cruccu G, Aziz TZ, Garcia-Larrea L, Hansson P, Jensen
TS, Lefaucheur JP, Simpson BA, Taylor RS. EFNS
guidelines on neurostimulation therapy for neuropathic
pain. Eur J Neurol 2007; 14(9): 952-70.
sites WeB d’intérêt
● American Pain Society :
www.ampainsoc.org
● Association québécoise de la douleur
chronique : www.douleurchronique.org
● International Association for the Study of Pain :
www.iasp-pain.org
● Société canadienne de la douleur :
www.canadianpainsociety.ca
● Société québécoise de la douleur :
www.sqd.ca
Divulgation des conflits d’intérêts
● Aline Boulanger : consultante/conférencière
invitée – Bayer Canada Inc., Biovail
Pharmaceuticals Canada Inc., GlaxoSmithKline
Inc., Janssen-Ortho Inc., Labopharm Inc.,
Laboratoires Paladin Inc., McNeil Canada Inc.,
Merck Frosst Canada ltée, PainCeptor Pharma,
Pfizer Canada Inc., Purdue Pharma Inc., Sanofiaventis
Canada Inc., Shire BioChem Inc.,
Valeant Canada Inc., Wyeth Canada
● Pierre Arsenault : conférencier invité – Janssen-
Ortho Inc., Merck Frosst Canada ltée, Pfizer
Canada Inc., Purdue Pharma Inc.; chercheur
(essais de phase IV) – AstraZeneca Canada
Inc., Janssen-Ortho Inc., Pfizer Canada Inc.,
Purdue Pharma Inc., Sanofi-aventis Canada
Inc., Wyeth Canada
● Alain Béland : consultant/conférencier invité –
Biovail Pharmaceuticals Canada Inc., Janssen-
Ortho Inc., McNeil Canada Inc., Pfizer Canada
Inc., Purdue Pharma Inc.
● André Bélanger : consultant/conférencier –
Allergan Canada Inc., Biovail Pharmaceuticals
Canada Inc., Bristol-Myers Squibb Canada Inc.,
Janssen-Ortho Inc., Merck Frosst Canada ltée,
Novartis Pharma Canada Inc., Novo Nordisk
Canada Inc., Pfizer Canada Inc., Purdue
Pharma Inc., Sanofi-aventis Canada Inc.,
Valeant Canada Inc.
● Christian Cloutier : consultant – Bayer Canada
Inc., Biovail Pharmaceuticals Canada Inc.,
Janssen-Ortho Inc., Pfizer Canada Inc., Purdue
Pharma Inc., Valeant Pharma Inc.
● Dominique Dion : consultante – Pfizer Canada
Inc., Purdue Pharma Inc.
● Pierre Dolbec : consultant/conférencier –
GlaxoSmithKline Inc., Janssen-Ortho Inc.,
Merck Frosst Canada ltée, Pfizer Canada Inc.,
Purdue Pharma Inc.
● Angela Genge : consultante – Pfizer Canada Inc.
● David Lussier : consultant/conférencier invité –
Janssen-Ortho Inc., Merck Frosst Canada ltée,
Pfizer Canada Inc., Purdue Pharma Inc.
● Serge Marchand : subvention/conférencier/
consultant – AstraZeneca Canada Inc., Bayer
Canada Inc., Edwards Foundation, Instituts de
recherche en santé du Canada, Janssen-Ortho
Inc., Merck Frosst Canada ltée, Pfizer Canada
Inc., Purdue Pharma Inc., Valeant Pharma Inc.
● Huu Tram Anh Nguyen : consultante/
conférencière invitée – Janssen-Ortho Inc.,
Merck Frosst Canada ltée, Pfizer Canada Inc.,
Purdue Pharma Inc., Valeant Canada Inc.
● Mark Ware : subvention/conférencier/
consultant – AstraZeneca Canada Inc., Bayer
Canada Inc., Cannasat Therapeutics Inc., GW
Pharma ltée, Solvay Pharma Inc., Valeant
Pharma Inc.; subvention salariale – Edwards
Foundation, Fonds de la recherche en santé du
Québec; subvention – Hecht Foundation,
Instituts de recherche en santé du Canada
● Robert Thiffault : consultant/conférencier –
Janssen-Ortho Inc., Pfizer Canada Inc., Purdue
Pharma Inc.; conférencier –Sandoz Canada
Inc., Valeant Canada Inc.